Drawing for BTSA9

USPTO serial 97474703

BTSA9

Reviewed by CopyMark Law Group

Reg. 7216379Status 700Registered
Filing date
Status date
Registration date
Nov 14, 2023
Examiner
JACKSON, STEVEN W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BTSA9?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lenny R. Jiang

Lenny R. Jiang PARATUS LAW GROUP, PLLC1765 GREENSBORO STATION PLACESUITE 320TYSONS CORNER, VA 22102

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for treatment of convulsion; therapeutic injectable pharmaceuticals for muscles; pharmaceutical preparations for treatment of sarcopenia; pharmaceutical preparations for treatment of cerebral palsy; pharmaceutical preparations for treatment of hyperhidrosis; pharmaceutical preparations for treatment of headache; pharmaceutical preparations for treatment of trembling disorder; pharmaceutical preparations for treatment of neurological disorder; injectable pharmaceuticals for treatment of ligaments; pharmaceutical preparations for treatment of autonomic nervous system disease; pharmaceutical preparations for treatment of wrinkly skin syndrome; analgesics; injectable pharmaceuticals for treatment of tendon; pharmaceutical preparations including Botolinium toxin; pharmaceutical preparations for treatment of smooth muscle disease; pharmaceutical preparations for treating myotony; pharmaceutical preparations for treating sports injuries; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting peripheral nervous system; adjuvants for medical purposes; drug delivery agents in the form of injectable solutions for medical purposes for intradermal use; pharmaceutical preparations for central nerve treatment; pharmaceutical preparations for chemical disorder treatment; pharmaceutical preparations for diagnosis of imperceptible wrinkles; chemical preparations for pharmaceutical or medical purposes for the treatment of wrinkles; medicines for human purposes for the treatment of wrinklesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 29, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 14, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 14, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 29, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 29, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 9, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 26, 2023FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jul 21, 2023ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jul 17, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 14, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2023DOCKASSIGNED TO EXAMINER—
Jul 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 28, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance